- Exchange: OTC BB
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Advanced Cell Technology Inc
Add to PortfolioACTC:US
0.08000 USD 0.00020 0.25%As of 20:10:00 ET on 05/25/2012.
Snapshot for Advanced Cell Technology Inc (ACTC)
| Open: | 0.08000 | Day's Range: | 0.08000 - 0.09000 | Volume: | 1,496,565 | Bid: | 0.07990 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 0.07980 | 52wk Range: | 0.06500 - 0.21600 | 1-Yr Rtn: | -58.33% | Ask: | 0.08000 |
Key Statistics for ACTC
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (-) | - |
| Earnings Per Share () (ttm) | -0.0400 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 165.91 |
| Shares Outstanding (M) | 2,073.93 |
| Enterprise Value (M USD) (ttm) | 156.77 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 320.4242 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/08/2012 |
More ACTC Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for ACTC
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for ACTC
Advanced Cell Technology, Inc. is a biotechnology company applying human embryonic stem cell technology in the emerging field of regenerative medicine.
| Gary H RabinChairman/Interim CEO | Robert P LanzaChief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page